N/A
Completed N=148
Healthy, Immunized Communities Study
vaccine hesitancy · Communicable Diseases in Children
Source: ClinicalTrials.gov NCT03854734 ↗
Enrolled (actual)
148
Serious AEs
—
Results posted
Jul 2024
Primary outcomePrimary: Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV) — 74.3; 83.3; 97.9; 93.0 percentage of participants
Summary
This project aims to understand how improving vaccine education and awareness can impact the number of parents who vaccinate, or intend to vaccine, their middle school-aged children with age-appropriate vaccines, including human papillomavirus (HPV), meningitis (MCV) and tetanus, diphtheria, pertussis (TDap).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV) |
74.3; 83.3; 97.9; 93.0; 72.9; 80.5 | — |
Eligibility Criteria
Inclusion Criteria
- 18 years or older
- Parents and guardians of children who attend a School District of Lancaster middle schools
- Individuals who read and understand English
- Individuals with an email address
Exclusion Criteria
- Individuals who are non-English speaking
- Parents/Guardians <18 years or older who do not have children attending a middle school in the School District of Lancaster
- Individuals who do not have an email address
- Individuals who plan on moving out of the Lancaster City area in the next year
Data sourced from ClinicalTrials.gov (NCT03854734). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.